Results 11 to 20 of about 10,534,234 (296)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)

Pharmaceuticals, 2023
Dyslipidemia treatment is of major importance in reducing the risk of atherosclerotic cardiovascular disease (ASCVD), which is still the most common cause of death worldwide. During the last decade, a novel lipid-lowering drug category has emerged, i.e.,
Niki Katsiki, Michal Vrablik, Maciej Banach, Ioanna Gouni-Berthold   +3 more
doaj   +3 more sources

Assessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)‐Free Low‐Density Lipoprotein Cholesterol [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Accurate measurement of the cholesterol within lipoprotein(a) (Lp[a]‐C) and its contribution to low‐density lipoprotein cholesterol (LDL‐C) has important implications for risk assessment, diagnosis, and treatment of atherosclerotic ...
Weili Zheng, Michael Chilazi, Jihwan Park, Vasanth Sathiyakumar, Leslie J. Donato, Jeffrey W. Meeusen, Mariana Lazo, Eliseo Guallar, Krishnaji R. Kulkarni, Allan S. Jaffe, Raul D. Santos, Peter P. Toth, Steven R. Jones, Seth S. Martin   +13 more
doaj   +3 more sources

Thinking beyond low-density lipoprotein cholesterol: strategies to further reduce cardiovascular risk

Vascular Health and Risk Management, 2009
Rakesh K Sharma1, Vibhuti N Singh2, Hanumanth K Reddy11Medical Center of South Arkansas, El Dorado, University of Arkansas for Medical Sciences, Little Rock, AR, USA; 2Bayfront Medical Center, University of South Florida, St. Petersburg, FL, USAAbstract:
Rakesh K Sharma, Vibhuti N Singh, Hanumanth K Reddy   +2 more
doaj   +1 more source

Oxidized low-density lipoprotein cholesterol and plaque vulnerability [PDF]

American Heart Journal Plus
Background: The oxidation of low-density lipoprotein cholesterol (LDL-C) plays a critical role in plaque inflammation and the subsequent high-risk plaque formation.
Jun Goto, Daisuke Kinoshita, Yoichiro Otaki, Seisei Ra, Hiroe Ono, Takafumi Mito, Taku Shikama, Shingo Tachibana, Shigehiko Kato, Tetsu Watanabe, Ik-Kyung Jang, Masafumi Watanabe   +11 more
doaj   +2 more sources

Low‐Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background Conventional "low‐density lipoprotein cholesterol (LDL‐C)" assays measure cholesterol content in both low‐density lipoprotein and lipoprotein(a) particles.
Peter Willeit, Calvin Yeang, Patrick M. Moriarty, Lena Tschiderer, Stephen A. Varvel, Joseph P. McConnell, Sotirios Tsimikas   +6 more
doaj   +3 more sources

Low high-density lipoprotein cholesterol: current status and future strategies for management

Vascular Health and Risk Management, 2010
Vibhuti Singh1, Rakesh Sharma2, Ajoy Kumar3, Prakash Deedwania41University of South Florida College of Medicine, and Suncoast Cardiovascular Center, St. Petersburg, Florida, USA; 2Heart and Vascular Institute of South Arkansas, University of Arkansas for
Vibhuti Singh, Rakesh Sharma, Ajoy Kumar, et al   +3 more
doaj   +1 more source

Effect of Pelacarsen on Lipoprotein(a) Cholesterol and Corrected Low-Density Lipoprotein Cholesterol [PDF]

Journal of the American College of Cardiology, 2022
Laboratory methods that report low-density lipoprotein cholesterol (LDL-C) include both LDL-C and lipoprotein(a) cholesterol [Lp(a)-C] content.The purpose of this study was to assess the effect of pelacarsen on directly measured Lp(a)-C and LDL-C corrected for its Lp(a)-C content.The authors evaluated subjects with a history of cardiovascular disease ...
Yeang, Calvin, Karwatowska-Prokopczuk, Ewa, Su, Fei, Dinh, Brian, Xia, Shuting, Witztum, Joseph L, Tsimikas, Sotirios   +6 more
openaire   +3 more sources

Lowering low-density lipoprotein cholesterol levels in patients with type 2 diabetes mellitus

International Journal of General Medicine, 2014
Harold E Bays Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY, USA Abstract: Type 2 diabetes mellitus (T2DM) is characterized by hyperglycemia, insulin resistance, and/or progressive loss of β-cell function.
Bays HE
doaj   +1 more source

The effect of Ramadan fasting on lipid profile in pregnant women [PDF]

Journal of Fasting and Health, 2015
Introduction: Abnormal lipid profile causes maternal mortality and impairs fetal development. This study investigated the effect of Ramadan fasting on plasma lipid profile in pregnant women.
Abolfazl Khoshdel, Soleiman Kheiri, Jafar Nasiri, Ebrahim Saedi, Mahmoud Mobasheri   +4 more
doaj   +3 more sources

Physiological Bases for the Superiority of Apolipoprotein B Over Low‐Density Lipoprotein Cholesterol and Non–High‐Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
In 2019, the European Society of Cardiology/European Atherosclerosis Society stated that apolipoprotein B (apoB) was a more accurate marker of cardiovascular risk than low‐density lipoprotein cholesterol (LDL‐C) and non–high‐density lipoprotein ...
Tamara Glavinovic, George Thanassoulis, Jacqueline de Graaf, Patrick Couture, Robert A. Hegele, Allan D. Sniderman   +5 more
doaj   +1 more source